---
title: "US IPO Weekly Recap: Aktis Oncology leads as first sizable 2026 IPO"
description: "This week, three IPOs and five SPACs were priced, with Aktis Oncology leading the way by raising $318 million at a $1 billion market cap. Buda Juice raised $20 million, and Atlas Critical Minerals rai"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/272131944.md"
published_at: "2026-01-09T23:28:50.000Z"
---

# US IPO Weekly Recap: Aktis Oncology leads as first sizable 2026 IPO

> This week, three IPOs and five SPACs were priced, with Aktis Oncology leading the way by raising $318 million at a $1 billion market cap. Buda Juice raised $20 million, and Atlas Critical Minerals raised $10 million. Five SPACs also priced, raising a total of $1.1 billion. Six IPOs submitted initial filings, including Brazilian digital bank PicS aiming for $500 million. The Renaissance IPO Index is up 3.9% year-to-date, outperforming the S&P 500's 1.1% increase.

Three IPOs and five SPACs priced this week. Six IPOs and two SPACs submitted initial filings.

In the first sizable deal of 2026, solid tumor biotech **Aktis Oncology** (AKTS) priced its upsized IPO at the high end of the range to raise $318 million at a $1.0 billion market cap. The company is a Phase 1 biotech developing alpha-emitting radiopharmaceuticals against prevalent solid tumors. Preclinical studies suggest superior efficacy vs. Padcev, but Aktis faces risk given its early-stage pipeline and lack of human data until at least 1Q27. Its pipeline features Ac-AKY-1189 for Nectin-4-expressing cancers and Ac-AKY-2519 targeting B7-H3-expressing tumors. Aktis finished the week up 24%.

Texas-based juice manufacturer **Buda Juice** (BUDA) priced its IPO at the low end of the range to raise $20 million at a $95 million market cap. The company states that it is pioneering the "UltraFresh" juice category through its end-to-end cold chain platform. Its product portfolio consists of fresh citrus juices and wellness shots across multiple brand lines and retail customers, which it believes demonstrates both brand diversification and private label manufacturing capabilities. Buda Juice finished the week up 9%.

While not included in the table below, Brazilian mineral exploration company **Atlas Critical Minerals** (ATCX) priced its upsized IPO at the low end of the range to raise $10 million at a $40 million market cap. The company’s portfolio includes rare earth and titanium prospects in Goiás and Minas Gerais, graphite properties in Minas Gerais, copper and nickel rights in Goiás and Piauí, and uranium-bearing areas across six states in Brazil. Atlas finished the week up 10%.

Five SPACs also priced this week. **Lafayette Digital Acquisition** (ZKPU) raised $250 million to target financial services and tech. **Bleichroeder Acquisition II** (BBCQU) raised $250 million to target technology. Daniel Cohen’s **Art Technology Acquisition** (ARTCU) raised $220 million to target tech, art, and finance. **Soren Acquisition** (SORNU) also raised $220 million to target healthcare. **Black Spade Acquisition** (BIIIU) raised $150 million to target leisure, entertainment, and digital assets.

  
Six IPOs submitted initial filings. Brazilan digital bank **PicS** (PICS) filed to raise an estimated $500 million. Budget furniture retailer **Bobs Discount Furniture** (BOBS) filed to raise an estimated $400 million. Electrical distribution equipment manufacturer **Forgent Power Solutions** (FPS) filed to raise an estimated $200 million. Hair loss biotech **Veradermics** (MANE) filed to raise $100 million. Oncology biotech **Eikon Therapeutics** (EIKN) filed to raise $100 million. Drug-resistant infection treatment developer **Lakewood-Amedex Biotherapeutics** (LABT) filed for a direct listing on the Nasdaq.

**  
IPO Market Snapshot**  
The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 1/8/2026, the Renaissance IPO Index was up 3.9% year-to-date, while the S&P 500 was up 1.1%. Renaissance Capital’s IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Reddit (RDDT) and Kenvue (KVUE). The Renaissance International IPO Index was up 7.2% year-to-date, while the ACWX was up 2.0%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Kioxia and Galderma.

### Related Stocks

- [BUDA.US - Buda Juice](https://longbridge.com/en/quote/BUDA.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 马年首家！盛合晶微 IPO 过会 | 盛合晶微半导体有限公司于 2 月 24 日成功通过上交所上市审核，成为马年首家科创板过会企业，拟募资 48 亿元。公司专注于集成电路晶圆级先进封测，致力于支持高性能芯片，尤其是 GPU、CPU 和 AI 芯片。此次 IPO 资金将用于三维多 | [Link](https://longbridge.com/en/news/276719832.md) |
| 美第奇新星生物技术｜8-K：2025 财年营收 40.97 万美元 |  | [Link](https://longbridge.com/en/news/276436519.md) |
| 上海龙旗科技在香港的 IPO 稳定期已结束 | 上海龙旗科技的香港 IPO 稳定期结束 | [Link](https://longbridge.com/en/news/276672349.md) |
| Sensata 科技控股｜8-K：2025 财年 Q4 营收 9.18 亿美元超过预期 |  | [Link](https://longbridge.com/en/news/276378500.md) |
| 库克兑现 6000 亿美元承诺：苹果加速休斯顿 AI 服务器生产，Mac mini 将首次实现 “美国制造” | 苹果 2 月 24 日宣布，今年晚些将在休斯顿首次启动 Mac mini 美国制造，并扩大 AI 服务器产能。自去年承诺 6000 亿美元对美投资以来，苹果已从 12 州采购超 200 亿颗芯片，台积电、环球晶圆、艾克尔等供应链项目相继落地 | [Link](https://longbridge.com/en/news/276740313.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.